发明名称 FUSED IMIDAZOLE DERIVATIVE
摘要 <p>A compound represented by the following formula (I), a prodrug thereof, or a pharmaceutically acceptable salt of either. The compound has high DPP-IV inhibitory activity and has been improved in safety, toxicity, etc. (I) [In the formula, R&lt;1&gt; represents hydrogen, optionally substituted alkyl, etc.; R&lt;2&gt; represents hydrogen, optionally substituted alkyl, optionally substituted aryl, etc.; R&lt;3&gt; represents hydrogen, optionally substituted aryl, etc.; and -Y-NH2 represents, e.g., a group represented by the formula (A) (wherein m is 0, 1, or 2; and R&lt;4&gt; is absent or one or two R&lt;4&gt;'s are present, the R&lt;4&gt;'s each independently representing optionally substituted alkyl, etc.).]</p>
申请公布号 WO2004096806(A1) 申请公布日期 2004.11.11
申请号 WO2004JP06104 申请日期 2004.04.27
申请人 SUMITOMO PHARMACEUTICALS CO. LTD.;NAKAHIRA, HIROYUKI;HOCHIGAI, HITOSHI 发明人 NAKAHIRA, HIROYUKI;HOCHIGAI, HITOSHI
分类号 A61K31/52;A61K31/5377;A61P1/00;A61P3/04;A61P13/08;A61P19/02;A61P19/10;A61P29/00;A61P31/18;A61P35/04;A61P37/06;A61P43/00;C07D473/18;(IPC1-7):C07D473/30;A61K31/537;C07D473/06;C07D473/04;C07D473/22 主分类号 A61K31/52
代理机构 代理人
主权项
地址